Jason P Rhodes
CIK 1577014 · President, CFO and Treasurer · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.99M
Companies
5
Total Filings
53
Lifetime Open-Market Net
-$108.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 2,962 | $26.71 | $79.1K | -$83.28M | 19 | 2026-07-08 |
| Generation Bio Co. (GBIO) Delisted | Director | 0 | $5.34 | $0 | -$18.24M | 14 | 2026-02-09 |
| REPL | Director | 946,000 | $13.65 | $12.91M | -$2.69M | 11 | 2022-04-05 |
| Disc Medicine, Inc. (GMTX) Delisted | Director | — | $13.50 | — | $0 | 1 | 2021-10-06 |
| Epizyme, Inc. (EPZM) Delisted | President, CFO and Treasurer | 138,000 | $1.47 | $202.9K | -$4.54M | 8 | 2014-09-24 |
Recent Filings · Page 2 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-18 | DYN | Sell (S) | −782 | -$25.9K | EDGAR |
| 2024-06-10 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | DYN | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | DYN | Sell (S) | −46,534 | -$1.40M | EDGAR |
| 2024-02-28 | DYN | Sell (S) | −807,838 | -$19.63M | EDGAR |
| 2024-02-23 | DYN | Sell (S) | −500,789 | -$11.34M | EDGAR |
| 2024-02-20 | DYN | Sell (S) | −510,152 | -$11.87M | EDGAR |
| 2023-06-12 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | DYN | Grant (A) | — | $0 | EDGAR |
| 2022-12-14 | DYN | Buy (P) | +934,581 | $10.00M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.